Sonoma Pharmaceuticals (SNOA) Asset Utilization Ratio (2011 - 2025)

Sonoma Pharmaceuticals' Asset Utilization Ratio history runs 15 years deep, the most recent figure standing at 1.29 for Q4 2025.

• In Q4 2025, Asset Utilization Ratio rose 26.25% year-over-year to 1.29; the TTM figure through Dec 2025 stood at 1.29 (up 26.25% YoY), while the FY2025 annual figure was 1.01, up 22.21% from the prior year.
• Asset Utilization Ratio was 1.29 for Q4 2025 at Sonoma Pharmaceuticals, up from 1.19 in the prior quarter.
• In the past five years, Asset Utilization Ratio ranged from a high of 1.29 in Q4 2025 to a low of 0.64 in Q4 2021.
• Historically, Asset Utilization Ratio has averaged 0.92 across 5 years, with a median of 0.88 in 2023.
• The sharpest annual moves came in 2021 and 2022: Asset Utilization Ratio slumped 44.21% in 2021, then jumped 36.35% in 2022.
• A 5-year view of Asset Utilization Ratio shows it stood at 0.64 in 2021, then jumped by 36.35% to 0.87 in 2022, then advanced by 0.25% to 0.87 in 2023, then increased by 17.24% to 1.02 in 2024, then grew by 26.25% to 1.29 in 2025.
• The last three Asset Utilization Ratio figures came in at 1.29 (Q4 2025), 1.19 (Q3 2025), and 1.05 (Q2 2025), per Business Quant data.